Terazosin Hydrochloride Capsule
FDA Label NDC 68788-9816

45 label sections · Submitted to the FDA by Preferred Pharmaceuticals, Inc · Indications, Dosage, Usage, and Precautions

Structured Product Label

The following Structured Product Label (SPL) was submitted to the FDA by Preferred Pharmaceuticals, Inc for the product Terazosin Hydrochloride (NDC 68788-9816). This document serves as the official prescribing information, containing essential scientific data and clinical materials required for healthcare providers and patients.

This specific version of the label includes detailed information regarding description, a. benign prostatic hyperplasia (bph), b. hypertension, pharmacokinetics, indications and usage, contraindications, syncope and “first-dose” effect, priapism, and other regulatory disclosures. Use the navigation below to review specific sections of the FDA submission.

Package/Label Display Panel

Terazosin Hydrochloride Capsules 2mg (58fe004c B69e 422e 8089 2ab1b59ceb4c 01)

Terazosin Hydrochloride Capsules 2mg (58fe004c B69e 422e 8089 2ab1b59ceb4c 01)

NDC 68788-9816
Terazosin Capsules,  USP
2 mg                      
                                        

PHARMACIST: Please  dispense with Patient Information Sheet.
CADISTATM


Terazosin Capsules,  USP

2 mg                      
                                         

PHARMACIST: Please  dispense with Patient Information Sheet.

CADISTATM

Rx Only
                       

Each Capsule Contains:

Terazosin Hydrochloride equivalent to terazosin 2 mg.

Usual Dosage:

See package insert for full prescribing information.

Dispense in tight, light-resistant container as defined in USP.

Store at 20-25°C (68-77°F)

[See USP Controlled Room Temperature].

Protect from light and moisture.

Manufactured by:
Jubilant Cadista Pharmaceuticals Inc.
Yardley, PA 19067, USA

Rev.# 08/24

TL
Repackaged By: Preferred Pharmaceuticals Inc.
384


Terazosin Hydrochloride Capsules 5mg (58fe004c B69e 422e 8089 2ab1b59ceb4c 00)

Terazosin Hydrochloride Capsules 5mg (58fe004c B69e 422e 8089 2ab1b59ceb4c 00)

Terazosin Hydrochloride equivalent to terazosin 5 mg.
NDC 68788-9815


Usual Dosage:

See package insert for full prescribing information.

Dispense in tight, light-resistant container as defined in USP.


Store at 20-25°C (68-77°F)
[See USP Controlled Room Temperature].

Protect from light and moisture.



Manufactured by:
Jubilant Cadista Pharmaceuticals Inc.
Yardley, PA 19067, USA
Rev.# 08/24

TL
Repackaged By: Preferred Pharmaceuticals Inc.
385

* Please review the disclaimer below.